Virtual West Oncology Conference
Video Player is loading.
10 seconds
Playback speed
2021 Update on ADT Intensification for mCSPC: What Are the Benefits & Survival Rates of Apalutamide? When It Should Be Administered for Better Outcomes?
By
Virtual West Oncology Conference
FEATURING
Daniel Vaena
By
Virtual West Oncology Conference
FEATURING
Daniel Vaena
Comments 0
Login to view comments.
Click here to Login
